According to data provided by Zacks Research, L Brands, Inc. (NYSE:LB) has a consensus target price of $52.833 on the stock. Out of the polled analysts providing targets, the high is currently $62, while the low is resting at $35. Analyst price targets may vary depending on the individual method used to calculate the estimate.
Turning to earnings, analysts are expecting L Brands, Inc. (NYSE:LB) to post a current quarter EPS of $0.24. This consensus number is compiled by Zacks Research. For the period ending on 2017-01-31, the company reported EPS for the quarter of $2.03. The resulting surprise factor from the difference between the reported number and the consensus estimate going into earnings was 6.84%. After a company reports earnings, the stock may see increased activity. The next earnings report date is scheduled on or near 2017-05-17.
In terms of analyst ratings, L Brands, Inc. (NYSE:LB) has a current ABR of 2.63. This average broker recommendation is given by Zacks using a scale from 1 to 5. According to this scale, a rating of 1 or 2 would indicate a Buy, and a rating of 4 or 5 would signify a Sell recommendation. A 3 would indicate a Hold on the stock.
For the current quarter, analysts are expecting Amgen Inc. (NASDAQ:AMGN) to report EPS of $3.07. This consensus estimate is provided by Zacks Research. After the period that ended on 2017-03-31, Amgen Inc. (NASDAQ:AMGN) reported an EPS actual of $3.15. The difference between the actual and estimate resulted in a surprise factor of 5%. The company is expected to release their next earnings report on or around 2017-07-26. Interested parties will be watching to see how company results compare to what the Street was projecting for the fiscal period.
Shares of Amgen Inc. (NASDAQ:AMGN) have a current ABR or average broker rating of 2.28. This consensus recommendation is also provided by Zacks Research. The recommendation falls on a scale between 1 and 5. A broker rating of 1 would translate into a Strong Buy. A rating of 5 would indicate a Strong Sell recommendation. This consensus broker rating may help shed some light on how the sell-side is currently viewing company stock.
Covering analysts often provide target price projections for company shares. The current Zacks consensus target price on shares of Amgen Inc. (NASDAQ:AMGN) is $181.909. The top analyst target is $209, and the lowest target is $160 on the stock. Because of the different techniques used to gauge a company target price, estimates may be quite different from one analyst to another.